UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the...
As filed with the Securities and Exchange Commission on April 21, 2021 Registration No. 333-238124 ...
As filed with the Securities and Exchange Commission on April 21, 2021 Registration No. 333-151263 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...
China Biologic Announces Completion of Going Private Transaction PR Newswire BEIJING, April 20, 2021 BEIJING, April 20, 2021 /PRNewswire/...
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020 PR Newswire BEIJING, March 29, 2021 BEIJING, March 29, 2021...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
China Biologic Announces Shareholders' Approval of Merger Agreement PR Newswire BEIJING, March 1, 2021 BEIJING, March 1, 2021 /PRNewswire/...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.